Treating skin cancers with surgery is still the standard of care for most NMSC patients. However, surgery is not without potential downsides, especially for patients with other health issues. Surface radiotherapy, both Electronic Brachytherapy (EBT) and Superficial Radiation Therapy (SRT), is an FDA-approved treatment option and an excellent choice for select NMSC patients. Explore the case study below to see how Dr. Steven Davis has had success treating patients with surface radiation therapy.
XBeam from Xstrahl Receives U.S. Food and Drug Administration (FDA) 510(k) Clearance for Use in the U.S.
Xstrahl’s XBeam has received FDA 510(k) Clearance for Use in the U.S. The XBeam technology streamlines radiotherapy treatment planning and simplifies patient workflow for treating skin cancer, benign diseases, and palliative care. Explore how this innovation enhances orthovoltage superficial radiotherapy (SRT) and electronic brachytherapy (eBt). With XBeam, you can calculate, protocol and export treatment plans for Xstrahl treatments with Radiant Aura and all other Xstrahl medical devices in the U.S. and worldwide.
